1. Home
  2. Pharma & Healthcare
  3. Global and Japan Adult Vaccine Market 2020 by Manufacturers, Type and Application, Forecast to 2025

Global and Japan Adult Vaccine Market 2020 by Manufacturers, Type and Application, Forecast to 2025

Publication Month: Mar 2020 | No. of Pages: 96 Published By: Global Info Research
Single User License: US $ 3980
Corporate User License: US $ 7960

Market Overview
The global Adult Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Adult Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Adult Vaccine market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Breakdown by Type, Adult Vaccine market has been segmented into Influenza, Cervical Cancer, Zoster Shingles, Pneumococcal, Meningococcal, MMRV, Hepatitis, DTP, Travel and Miscellaneous, etc.

Breakdown by Application, Adult Vaccine has been segmented into Hospitals, Medical Care Centers, Other, etc.

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Adult Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Adult Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Adult Vaccine market.

For Japan, this report analyses the Japan market by players, Type and Application, for the period 2015-2025.

Competitive Landscape and Adult Vaccine Market Share Analysis
Adult Vaccine competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Adult Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Adult Vaccine sales, revenue and market share for each player covered in this report.

The major players covered in Adult Vaccine are: GlaxoSmithKline, Novartis, Sanofi Pasteur, Protein Sciences, Merck, BioCSL (Seqirus), Pfizer, etc. Among other players domestic and global, Adult Vaccine market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The key market players for global Adult Vaccine market are listed below:
GlaxoSmithKline
Novartis
Sanofi Pasteur
Protein Sciences
Merck
BioCSL (Seqirus)
Pfizer

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)

Market segment by Type, covers:
Influenza
Cervical Cancer
Zoster Shingles
Pneumococcal
Meningococcal
MMRV
Hepatitis
DTP
Travel and Miscellaneous

Market segment by Application, can be divided into
Hospitals
Medical Care Centers
Other

Table of Contents

1 Market Overview
1.1 Adult Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Adult Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Influenza
1.2.3 Cervical Cancer
1.2.4 Zoster Shingles
1.2.5 Pneumococcal
1.2.6 Meningococcal
1.2.7 MMRV
1.2.8 Hepatitis
1.2.9 DTP
1.2.10 Travel and Miscellaneous
1.3 Market Analysis by Application
1.3.1 Overview: Global Adult Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Medical Care Centers
1.3.4 Other
1.4 Global Adult Vaccine Market Size and Forecast (2015-2025)
1.4.1 Global Adult Vaccine Revenue and Forecast (2015-2025)
1.4.2 Global Adult Vaccine Sales and Forecast (2015-2025)
1.5 Global Adult Vaccine Market Size Overview by Geography (2015-2020)
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GlaxoSmithKline SWOT Analysis
2.1.4 GlaxoSmithKline Product and Services
2.1.5 GlaxoSmithKline Adult Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Novartis SWOT Analysis
2.2.4 Novartis Product and Services
2.2.5 Novartis Adult Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi Pasteur
2.3.1 Sanofi Pasteur Details
2.3.2 Sanofi Pasteur Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sanofi Pasteur SWOT Analysis
2.3.4 Sanofi Pasteur Product and Services
2.3.5 Sanofi Pasteur Adult Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Protein Sciences
2.4.1 Protein Sciences Details
2.4.2 Protein Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Protein Sciences SWOT Analysis
2.4.4 Protein Sciences Product and Services
2.4.5 Protein Sciences Adult Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck
2.5.1 Merck Details
2.5.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Merck SWOT Analysis
2.5.4 Merck Product and Services
2.5.5 Merck Adult Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 BioCSL (Seqirus)
2.6.1 BioCSL (Seqirus) Details
2.6.2 BioCSL (Seqirus) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 BioCSL (Seqirus) SWOT Analysis
2.6.4 BioCSL (Seqirus) Product and Services
2.6.5 BioCSL (Seqirus) Adult Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Pfizer SWOT Analysis
2.7.4 Pfizer Product and Services
2.7.5 Pfizer Adult Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Global Adult Vaccine Market, Company Landscape
3.1 Company Market Share Analysis: Global
3.1.1 Global Adult Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.1.2 Global Adult Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.2 Company Market Share Analysis: Japan
3.2.1 Key Players Adult Vaccine Sales in Japan (2018-2019)
3.2.2 Japan Adult Vaccine Revenue Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Adult Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Adult Vaccine Manufacturer Market Share in 2019
4 Market Size by Geography
4.1 Global Adult Vaccine Market Size by Geography (2015-2020)
4.1.1 Global Adult Vaccine Sales by Geography (2015-2020)
4.1.2 Global Adult Vaccine Revenue by Regions (2015-2020)
4.2 Global Adult Vaccine Market Size and Forecast by Regions (2020-2025)
4.2.1 Global Adult Vaccine Sales and Forecast by Regions (2020-2025)
4.2.2 Global Adult Vaccine Revenue and Forecast by Regions (2020-2025)
4.3 North America Adult Vaccine Market Size and Forecast (2015-2025)
4.4 Europe Adult Vaccine Market Size and Forecast (2015-2025)
4.5 Asia-Pacific Adult Vaccine Market Size and Forecast (2015-2025)
4.6 South America Adult Vaccine Market Size and Forecast (2015-2025)
4.7 Middle East and Africa Adult Vaccine Market Size and Forecast (2015-2025)
5 North America by Country
5.1 North America Adult Vaccine Market Size by Country (2015-2020)
5.1.1 North America Adult Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Adult Vaccine Revenue and Market Share by Country (2015-2020)
5.2 North America Adult Vaccine Market Size and Forecast by Country (2020-2025)
5.2.1 North America Adult Vaccine Sales and Forecast by Country (2020-2025)
5.2.2 North America Adult Vaccine Revenue and Forecast by Country (2020-2025)
5.3 United States Adult Vaccine Market Size and Forecast (2015-2025)
5.4 Canada Adult Vaccine Market Size and Forecast (2015-2025)
5.5 Mexico Adult Vaccine Market Size and Forecast (2015-2025)
6 Europe by Country
6.1 Europe Adult Vaccine Market Size by Country (2015-2020)
6.1.1 Europe Adult Vaccine Sales by Country (2015-2020)
6.1.2 Europe Adult Vaccine Revenue by Country (2015-2020)
6.2 Europe Adult Vaccine Market Size and Forecast by Country (2020-2025)
6.2.1 Europe Adult Vaccine Sales and Forecast by Country (2020-2025)
6.2.2 Europe Adult Vaccine Revenue and Forecast by Country (2020-2025)
6.3 Germany Adult Vaccine Market Size and Forecast (2015-2025)
6.4 United Kingdom Adult Vaccine Market Size and Forecast (2015-2025)
6.5 France Adult Vaccine Market Size and Forecast (2015-2025)
6.6 Russia Adult Vaccine Market Size and Forecast (2015-2025)
6.7 Italy Adult Vaccine Market Size and Forecast (2015-2025)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Adult Vaccine Market Size by Region (2015-2020)
7.1.1 Asia-Pacific Adult Vaccine Sales by Region (2015-2020)
7.1.2 Asia-Pacific Adult Vaccine Revenue by Region (2015-2020)
7.2 Asia-Pacific Adult Vaccine Market Size and Forecast by Region (2020-2025)
7.2.1 Asia-Pacific Adult Vaccine Sales and Forecast by Region (2020-2025)
7.2.2 Asia-Pacific Adult Vaccine Revenue and Forecast by Region (2020-2025)
7.3 China Adult Vaccine Market Size and Forecast (2015-2025)
7.4 Japan Adult Vaccine Market Size and Forecast (2015-2025)
7.5 Korea Adult Vaccine Market Size and Forecast (2015-2025)
7.6 India Adult Vaccine Market Size and Forecast (2015-2025)
7.7 Southeast Asia Adult Vaccine Market Size and Forecast (2015-2025)
7.8 Australia Adult Vaccine Market Size and Forecast (2015-2025)
8 South America by Country
8.1 South America Adult Vaccine Market Size by Country (2015-2020)
8.1.1 South America Adult Vaccine Sales by Country (2015-2020)
8.1.2 South America Adult Vaccine Revenue by Country (2015-2020)
8.2 South America Adult Vaccine Market Size and Forecast by Country (2020-2025)
8.2.1 South America Adult Vaccine Sales and Forecast by Country (2020-2025)
8.2.2 South America Adult Vaccine Revenue and Forecast by Country (2020-2025)
8.3 Brazil Adult Vaccine Market Size and Forecast (2015-2025)
8.4 Argentina Adult Vaccine Market Size and Forecast (2015-2025)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Adult Vaccine Market Size by Country (2015-2020)
9.1.1 Middle East & Africa Adult Vaccine Sales by Country (2015-2020)
9.1.2 Middle East & Africa Adult Vaccine Revenue by Country (2015-2020)
9.2 Middle East & Africa Adult Vaccine Market Size and Forecast by Country (2020-2025)
9.2.1 Middle East & Africa Adult Vaccine Sales and Forecast by Country (2020-2025)
9.2.2 Middle East & Africa Adult Vaccine Revenue and Forecast by Country (2020-2025)
9.3 Saudi Arabia Adult Vaccine Market Size and Forecast (2015-2025)
9.4 Turkey Adult Vaccine Market Size and Forecast (2015-2025)
9.5 Egypt Adult Vaccine Market Size and Forecast (2015-2025)
9.6 South Africa Adult Vaccine Market Size and Forecast (2015-2025)
10 Market Segment by Type
10.1 Global Adult Vaccine Market Size by Type (2015-2020)
10.1.1 Global Adult Vaccine Sales by Type (2015-2020)
10.1.2 Global Adult Vaccine Revenue by Type (2015-2020)
10.1.3 Global Adult Vaccine Price by Type (2015-2020)
10.2 Global Adult Vaccine Market Size and Forecast by Type (2020-2025)
10.2.1 Global Adult Vaccine Sales and Forecast by Type (2020-2025)
10.2.2 Global Adult Vaccine Revenue and Forecast by Type (2020-2025)
10.2.3 Global Adult Vaccine Price and Forecast by Type (2020-2025)
10.3 Japan Adult Vaccine Market Size and Forecast by Type (2015-2025)
10.3.1 Japan Adult Vaccine Market Size by Type (2015-2020)
10.3.2 Japan Adult Vaccine Market Size and Forecast by Type (2020-2025)
11 Market Segment by Application
11.1 Global Adult Vaccine Market Size by Application (2015-2020)
11.1.1 Global Adult Vaccine Sales by Application (2015-2020)
11.1.2 Global Adult Vaccine Revenue by Application (2015-2020)
11.1.3 Global Adult Vaccine Price by Application (2015-2020)
11.2 Global Adult Vaccine Market Size and Forecast by Application (2020-2025)
11.2.1 Global Adult Vaccine Sales and Forecast by Application (2020-2025)
11.2.2 Global Adult Vaccine Revenue and Forecast by Application (2020-2025)
11.2.3 Global Adult Vaccine Price and Forecast by Application (2020-2025)
11.3 Japan Adult Vaccine Market Size and Forecast by Application (2015-2025)
11.3.1 Japan Adult Vaccine Market Size by Application (2015-2020)
11.3.2 Japan Adult Vaccine Market Size and Forecast by Application (2020-2025)
12 Sales Channel, Distributors, Costumers, and Market Dynamics
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Distributors, Traders and Dealers
12.4.1 Market Opportunities
12.4.2 Market Risk
12.4.3 Market Driving Force
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

Tables and Figures

List of Tables

Table 1. Global Adult Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Adult Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Adult Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Adult Vaccine Market Size Overview by Geography (2015-2020) (USD Million)
Table 5. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 6. GlaxoSmithKline Adult Vaccine Major Business
Table 7. GlaxoSmithKline Adult Vaccine Total Revenue (USD Million) (2018-2019)
Table 8. GlaxoSmithKline SWOT Analysis
Table 9. GlaxoSmithKline Adult Vaccine Product and Services
Table 10. GlaxoSmithKline Adult Vaccine Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 11. Novartis Basic Information, Manufacturing Base and Competitors
Table 12. Novartis Adult Vaccine Major Business
Table 13. Novartis Adult Vaccine Total Revenue (USD Million) (2018-2019)
Table 14. Novartis SWOT Analysis
Table 15. Novartis Adult Vaccine Product and Services
Table 16. Novartis Adult Vaccine Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 17. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 18. Sanofi Pasteur Adult Vaccine Major Business
Table 19. Sanofi Pasteur Adult Vaccine Total Revenue (USD Million) (2018-2019)
Table 20. Sanofi Pasteur SWOT Analysis
Table 21. Sanofi Pasteur Adult Vaccine Product and Services
Table 22. Sanofi Pasteur Adult Vaccine Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 23. Protein Sciences Basic Information, Manufacturing Base and Competitors
Table 24. Protein Sciences Adult Vaccine Major Business
Table 25. Protein Sciences Adult Vaccine Total Revenue (USD Million) (2018-2019)
Table 26. Protein Sciences SWOT Analysis
Table 27. Protein Sciences Adult Vaccine Product and Services
Table 28. Protein Sciences Adult Vaccine Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 29. Merck Basic Information, Manufacturing Base and Competitors
Table 30. Merck Adult Vaccine Major Business
Table 31. Merck Adult Vaccine Total Revenue (USD Million) (2018-2019)
Table 32. Merck SWOT Analysis
Table 33. Merck Adult Vaccine Product and Services
Table 34. Merck Adult Vaccine Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 35. BioCSL (Seqirus) Basic Information, Manufacturing Base and Competitors
Table 36. BioCSL (Seqirus) Adult Vaccine Major Business
Table 37. BioCSL (Seqirus) Adult Vaccine Total Revenue (USD Million) (2018-2019)
Table 38. BioCSL (Seqirus) SWOT Analysis
Table 39. BioCSL (Seqirus) Adult Vaccine Product and Services
Table 40. BioCSL (Seqirus) Adult Vaccine Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 41. Pfizer Basic Information, Manufacturing Base and Competitors
Table 42. Pfizer Adult Vaccine Major Business
Table 43. Pfizer Adult Vaccine Total Revenue (USD Million) (2018-2019)
Table 44. Pfizer SWOT Analysis
Table 45. Pfizer Adult Vaccine Product and Services
Table 46. Pfizer Adult Vaccine Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 47. Global Adult Vaccine Sales by Manufacturer (2018-2019) (K MT)
Table 48. Global Adult Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 49. Key Players Adult Vaccine Sales in Japan (2018-2019) (K MT)
Table 50. Key Players Adult Vaccine Sales Market Share in Japan (2018-2019)
Table 51. Key Players Revenue of Adult Vaccine in Japan (2018-2019) (USD Million)
Table 52. Global Adult Vaccine Sales by Regions (2015-2020) (K MT)
Table 53. Global Adult Vaccine Sales Market Share by Regions (2015-2020)
Table 54. Global Adult Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 55. Global Adult Vaccine Sales and Forecast by Regions (2020-2025) (K MT)
Table 56. Global Adult Vaccine Sales Market Share by Regions (2020-2025)
Table 57. Global Adult Vaccine Revenue and Forecast by Regions (2020-2025) (USD Million)
Table 58. Global Adult Vaccine Revenue Market Share by Regions (2020-2025) (USD Million)
Table 59. North America Adult Vaccine Sales by Countries (2015-2020) (K MT)
Table 60. North America Adult Vaccine Sales Market Share by Countries (2015-2020)
Table 61. North America Adult Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 62. North America Adult Vaccine Revenue Market Share by Countries (2015-2020)
Table 63. North America Adult Vaccine Sales by Country (2020-2025) (K MT)
Table 64. North America Adult Vaccine Sales Market Share by Country (2020-2025)
Table 65. North America Adult Vaccine Revenue by Country (2020-2025) (USD Million)
Table 66. North America Adult Vaccine Revenue Market Share by Country (2020-2025)
Table 67. Europe Adult Vaccine Sales by Countries (2015-2020) (K MT)
Table 68. Europe Adult Vaccine Sales Market Share by Countries (2015-2020)
Table 69. Europe Adult Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 70. Europe Adult Vaccine Revenue Market Share by Countries (2015-2020)
Table 71. Europe Adult Vaccine Sales by Country (2020-2025) (K MT)
Table 72. Europe Adult Vaccine Sales Market Share by Country (2020-2025)
Table 73. Europe Adult Vaccine Revenue by Country (2020-2025) (USD Million)
Table 74. Europe Adult Vaccine Revenue Market Share by Country (2020-2025)
Table 75. Asia-Pacific Adult Vaccine Sales by Countries (2015-2020) (K MT)
Table 76. Asia-Pacific Adult Vaccine Sales Market Share by Countries (2015-2020)
Table 77. Asia-Pacific Adult Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 78. Asia-Pacific Adult Vaccine Revenue Market Share by Countries (2015-2020)
Table 79. Asia-Pacific Adult Vaccine Sales by Country (2020-2025) (K MT)
Table 80. Asia-Pacific Adult Vaccine Sales Market Share by Country (2020-2025)
Table 81. Asia-Pacific Adult Vaccine Revenue by Country (2020-2025) (USD Million)
Table 82. Asia-Pacific Adult Vaccine Revenue Market Share by Country (2020-2025)
Table 83. South America Adult Vaccine Sales by Countries (2015-2020) (K MT)
Table 84. South America Adult Vaccine Sales Market Share by Countries (2015-2020)
Table 85. South America Adult Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 86. South America Adult Vaccine Revenue Market Share by Countries (2015-2020)
Table 87. South America Adult Vaccine Sales by Country (2020-2025) (K MT)
Table 88. South America Adult Vaccine Sales Market Share by Country (2020-2025)
Table 89. South America Adult Vaccine Revenue by Country (2020-2025) (USD Million)
Table 90. South America Adult Vaccine Revenue Market Share by Country (2020-2025)
Table 91. Middle East & Africa Adult Vaccine Sales by Countries (2015-2020) (K MT)
Table 92. Middle East & Africa Adult Vaccine Sales Market Share by Countries (2015-2020)
Table 93. Middle East & Africa Adult Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 94. Middle East & Africa Adult Vaccine Revenue Market Share by Countries (2015-2020)
Table 95. Middle East & Africa Adult Vaccine Sales by Country (2020-2025) (K MT)
Table 96. Middle East & Africa Adult Vaccine Sales Market Share by Country (2020-2025)
Table 97. Middle East & Africa Adult Vaccine Revenue by Country (2020-2025) (USD Million)
Table 98. Middle East & Africa Adult Vaccine Revenue Market Share by Country (2020-2025)
Table 99. Japan Adult Vaccine Sales by Type (2015-2020) (K MT)
Table 100. Japan Adult Vaccine Sales Market Share by Type (2015-2020)
Table 101. Japan Adult Vaccine Revenue by Type (2015-2020) (USD Million)
Table 102. Japan Adult Vaccine Revenue Market Share by Type (2015-2020)
Table 103. Japan Adult Vaccine Sales by Type (2020-2025) (K MT)
Table 104. Japan Adult Vaccine Sales Market Share by Type (2020-2025)
Table 105. Japan Adult Vaccine Revenue by Type (2020-2025) (USD Million)
Table 106. Japan Adult Vaccine Revenue Market Share by Type (2020-2025)
Table 107. Global Adult Vaccine Sales by Application (2015-2020) (K MT)
Table 108. Global Adult Vaccine Sales Market Share by Application (2015-2020)
Table 109. Global Adult Vaccine Revenue by Application (2015-2020) (USD Million)
Table 110. Global Adult Vaccine Revenue Market Share by Application (2015-2020)
Table 111. Global Adult Vaccine Price by Application (2015-2020) (USD/MT)
Table 112. Global Adult Vaccine Sales by Application (2020-2025) (K MT)
Table 113. Global Adult Vaccine Sales Market Share by Application (2020-2025)
Table 114. Global Adult Vaccine Revenue by Application (2020-2025) (USD Million)
Table 115. Global Adult Vaccine Revenue Market Share by Application (2020-2025)
Table 116. Global Adult Vaccine Price by Application (2020-2025) (USD/MT)
Table 117. Japan Adult Vaccine Sales by Application (2015-2020) (K MT)
Table 118. Japan Adult Vaccine Sales Market Share by Application (2015-2020)
Table 119. Japan Adult Vaccine Revenue by Application (2015-2020) (USD Million)
Table 120. Japan Adult Vaccine Revenue Market Share by Application (2015-2020)
Table 121. Japan Adult Vaccine Sales by Application (2020-2025) (K MT)
Table 122. Japan Adult Vaccine Sales Market Share by Application (2020-2025)
Table 123. Japan Adult Vaccine Revenue by Application (2020-2025) (USD Million)
Table 124. Japan Adult Vaccine Revenue Market Share by Application (2020-2025)
Table 125. Direct Channel Pros & Cons
Table 126. Indirect Channel Pros & Cons
Table 127. Distributors/Traders/ Dealers List
Table 128. Customers of Adult Vaccine
Table 129. Market Opportunities in Next Few Years
Table 130. Market Risks Analysis
Table 131. Market Drivers
List of Figures
Figure 1. Adult Vaccine Picture
Figure 2. Global Adult Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Influenza Picture
Figure 4. Cervical Cancer Picture
Figure 5. Zoster Shingles Picture
Figure 6. Pneumococcal Picture
Figure 7. Meningococcal Picture
Figure 8. MMRV Picture
Figure 9. Hepatitis Picture
Figure 10. DTP Picture
Figure 11. Travel and Miscellaneous Picture
Figure 12. Adult Vaccine Sales Market Share by Application in 2019
Figure 13. Hospitals Picture
Figure 14. Medical Care Centers Picture
Figure 15. Other Picture
Figure 16. Global Adult Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 17. Global Adult Vaccine Sales Growth Rate (2015-2025) (K MT)
Figure 18. Global Adult Vaccine Sales Market Share by Manufacturer in 2019
Figure 19. Global Adult Vaccine Revenue Market Share by Manufacturer in 2019
Figure 20. Key Players Adult Vaccine Revenue Market Share in Japan in 2019
Figure 21. Global Top 5 Adult Vaccine Manufacturer Market Share in 2019
Figure 22. Top 3 Adult Vaccine Players Market Share in Japan in 2019
Figure 23. Global Adult Vaccine Revenue Market Share by Regions in 2019
Figure 24. North America Adult Vaccine Sales YoY Growth (2015-2025) (K MT)
Figure 25. North America Adult Vaccine Revenue YoY Growth (2015-2025) (USD Million)
Figure 26. Europe Adult Vaccine Sales YoY Growth (2015-2020) (K MT)
Figure 27. Europe Adult Vaccine Revenue YoY Growth (2015-2020) (USD Million)
Figure 28. Asia-Pacific Adult Vaccine Sales YoY Growth (2015-2020) (K MT)
Figure 29. Asia-Pacific Adult Vaccine Revenue YoY Growth (2015-2020) (USD Million)
Figure 30. South America Adult Vaccine Sales YoY Growth (2015-2020) (K MT)
Figure 31. South America Adult Vaccine Revenue YoY Growth (2015-2020) (USD Million)
Figure 32. Middle East & Africa Adult Vaccine Sales YoY Growth (2015-2020) (K MT)
Figure 33. Middle East & Africa Adult Vaccine Revenue YoY Growth (2015-2020) (USD Million)
Figure 34. North America Adult Vaccine Sales Market Share by Country in 2019
Figure 35. North America Adult Vaccine Revenue Market Share by Country in 2019
Figure 36. United States Adult Vaccine Market Size and Growth Rate (2015-2025) (USD Million)
Figure 37. Canada Adult Vaccine Market Size and Growth Rate (2015-2025) (USD Million)
Figure 38. Mexico Adult Vaccine Market Size and Growth Rate (2015-2020) (USD Million)
Figure 39. Europe Adult Vaccine Revenue Market Share by Country in 2019
Figure 40. Germany Adult Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 41. United Kingdom Adult Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 42. France Adult Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 43. Russia Adult Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 44. Italy Adult Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 45. Asia-Pacific Adult Vaccine Sales Market Share by Region 2018
Figure 46. Asia-Pacific Adult Vaccine Revenue Market Share by Region 2018
Figure 47. China Adult Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 48. Japan Adult Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 49. Korea Adult Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 50. India Adult Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 51. Southeast Asia Adult Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 52. Australia Adult Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 53. South America Adult Vaccine Sales Market Share by Country in 2019
Figure 54. South America Adult Vaccine Revenue Market Share by Country in 2019
Figure 55. Brazil Adult Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 56. Argentina Adult Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 57. Saudi Arabia Adult Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 58. Turkey Adult Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 59. Egypt Adult Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 60. South Africa Adult Vaccine Market Size Growth Rate (2015-2025) (USD Million)
Figure 61. Global Revenue Market Share of Adult Vaccine by Type in 2019
Figure 62. Global Revenue Market Share of Adult Vaccine by Application in 2019
Figure 63. Sales Channel: Direct Channel vs Indirect Channel




Companies Mentioned
GlaxoSmithKline
Novartis
Sanofi Pasteur
Protein Sciences
Merck
BioCSL (Seqirus)
Pfizer

Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets